Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Investing Activities: 2017-2024

Historic Cash from Investing Activities for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $8.6 million.

  • DiaMedica Therapeutics' Cash from Investing Activities rose 7653.85% to $1.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$3.9 million, marking a year-over-year decrease of 7716.00%. This contributed to the annual value of $8.6 million for FY2024, which is 146.80% up from last year.
  • Per DiaMedica Therapeutics' latest filing, its Cash from Investing Activities stood at $8.6 million for FY2024, which was up 146.80% from -$18.3 million recorded in FY2023.
  • In the past 5 years, DiaMedica Therapeutics' Cash from Investing Activities registered a high of $11.5 million during FY2022, and its lowest value of -$20.5 million during FY2021.
  • Over the past 3 years, DiaMedica Therapeutics' median Cash from Investing Activities value was $8.6 million (recorded in 2024), while the average stood at $601,000.
  • Per our database at Business Quant, DiaMedica Therapeutics' Cash from Investing Activities slumped by 312.85% in 2020 and then skyrocketed by 156.18% in 2022.
  • DiaMedica Therapeutics' Cash from Investing Activities (Yearly) stood at -$16.1 million in 2020, then dropped by 27.29% to -$20.5 million in 2021, then soared by 156.18% to $11.5 million in 2022, then slumped by 258.60% to -$18.3 million in 2023, then surged by 146.80% to $8.6 million in 2024.